The relationships between the expression of autocrine motility factor receptor and the clinical features of papillary thyroid carcinoma
10.3760/cma.j.issn.1008-1372.2012.06.009
- VernacularTitle:自分泌运动因子受体的表达与甲状腺乳头状癌的临床关系研究
- Author:
Qian XIE
;
Fan ZHANG
;
Zhimao JIANG
;
Yali DAI
;
Ningbo ZHANG
- Publication Type:Journal Article
- Keywords:
Receptors,autocrine motility factor/metabolism;
Thyroid neoplasms/metabolism/pathology;
Carcinoma,papillary/metabolism/pathology
- From:
Journal of Chinese Physician
2012;14(6):750-752,755
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the expression of autocrine motility factor receptor (AMFR)in papillary thyroid carcinoma and its relationship with clinical characteristics of this disease.Methods Real - time quantitative PCR and immunohistochemical methods were used to analyze the expression of AMFR in papillary thyroid carcinomas.ResultsThe significant differences in AMFR expression between papillary thyroid carcinoma and normal thyroid tissues were found in the levels of mRNA (6.296 ± 1.568 vs 7.913 ± 2.351,t=3.681,P=0.001 ) and protein ( 63.1% vs 34.5 %,x2=13.722,P < 0.001 ),respectively.Immunohistochemistry analyses showed that the protein expression of AMFR in papillary thyroid carcinomas were significantly correlated with tumour size ( x2=5.209,P < 0.05 ) and lymph node metastasis ( x2=4.32,P < 0.05 ),and it was affected by the factors age ( x2=0.739,P=0.39 ) and gender ( x2=0.064,P=0.81 ).ConclusionsThe increased AMFR in papillary thyroid carcinoma would be a new target for cancer therapy and a new marker for prognosis.